Medical Condition News

RSS

UCL awarded 20M grant to establish The Leonard Wolfson Experimental Neurology Centre

A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a -20million grant from the Wolfson Foundation, it was announced today.

19 Dec 2011

Second-hand smoke exposure during childhood associated with aspirin-exacerbated respiratory disease

Need another reason to keep your New Year's resolution to stop smoking? A first-of-its-kind study found adults with aspirin-exacerbated respiratory disease were more than three times as likely to have been exposed to second-hand smoke during childhood as those without the condition.

19 Dec 2011

Studies confirm potential of EarlySense system as risk assessment tool for preventing pressure ulcers

EarlySense, a market leader in proactive patient care solutions, announced today post regulatory approval clinical and interventional study results further confirming the EarlySense contact-free patient monitoring system's high value as a risk assessment tool for preventing pressure ulcers.

19 Dec 2011

Lixte's LB-205 shows therapeutic potential against Gaucher disease

An article in the early edition (December 12, 2011) of the Proceedings of the National Academy of Sciences USA, reported that Lixte's investigational drug, LB-205, was shown to have therapeutic potential in a laboratory model of Gaucher disease.

19 Dec 2011

ALS TDI, Biogen Idec and UCB enter agreement to study anti-CD40L antibody for ALS

The ALS Therapy Development Institute today announced a research agreement with Biogen Idec and UCB Pharma SA to investigate the use of an anti-CD40L antibody as a potential therapy for Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's or Motor Neuron Disease.

19 Dec 2011

Alkermes commences ALKS 9070 phase 3 clinical trial for schizophrenia

Alkermes plc today announced the initiation of a phase 3 clinical trial of ALKS 9070 for the treatment of schizophrenia. ALKS 9070, a proprietary Alkermes molecule, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY for the treatment of a number of central nervous system disorders.

19 Dec 2011

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

APEIRON Biologics AG announced today that GlaxoSmithKline, exclusive, worldwide licensee for Apeiron's new investigational recombinant human Angiotensin Converting Enzyme 2 (rhACE2, name: GSK2586881, formerly APN01), has initiated a phase IIa study in patients suffering from Acute Lung Injury.

19 Dec 2011

Zalicus commences Z944 Phase 1 clinical trial for treatment of acute and inflammatory pain

Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced the initiation of a Phase 1 clinical trial evaluating the pharmacokinetics and safety of Z944, a novel oral T-type calcium channel blocker with demonstrated preclinical potential for the treatment of acute and inflammatory pain.

19 Dec 2011

Soybean compounds can increase effectiveness of radiation treatment for lung cancer

A Wayne State University researcher has shown that compounds found in soybeans can make radiation treatment of lung cancer tumors more effective while helping to preserve normal tissue.

19 Dec 2011

IGN joins BCCA Genome Science Center

Illumina, Inc. today announced that the British Columbia Cancer Agency's (BCCA) Genome Science Center has joined the Illumina Genome Network (IGN). IGN is designed to link researchers needing large-scale whole human genome sequencing with leading institutions that provide this application as a service using industry-leading Illumina sequencing platforms.

19 Dec 2011

Diseases of the Colon & Rectum publishes results from Pacira's EXPAREL Phase 3 trial

Pacira Pharmaceuticals, Inc. today announced the publication of data from a placebo-controlled, pivotal Phase 3 trial of EXPAREL (bupivacaine liposome injectable suspension), a non-opioid local analgesic that was recently approved by the U.S. Food and Drug Administration (FDA) for administration into the surgical site to produce postsurgical analgesia.

19 Dec 2011

arGEN-X to advance SIMPLE Antibody platform for treatment of autoimmune disorders

arGEN-X, a biopharmaceutical company focused on the discovery and development of human monoclonal antibodies from its proprietary SIMPLE Antibody platform, announced today it has received a grant of €1.3 million to further advance its powerful discovery platform for addressing challenging disease targets.

19 Dec 2011

UCL to establish new center for treatment of neurodegenerative diseases

A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a £20million grant from the Wolfson Foundation, it was announced today.

19 Dec 2011

Study finds knee pain patterns vary among women over a 12-year period

New research shows 63% of women age 50 and older reported persistent, incident, or intermittent knee pain during a 12-year study period. Predictors for persistent pain included higher body mass index (BMI), previous knee injury, and radiographic osteoarthritis.

19 Dec 2011

The Academy of Nutrition and Dietetics to expand coverage of MNT

The Academy of Nutrition and Dietetics has prepared a request to submit to the Centers for Medicare and Medicaid Services (CMS) to expand coverage of medical nutrition therapy (MNT) for specific diseases, including hypertension, obesity, and cancer, as part of the CMS National Coverage Determination (NCD) Process.

19 Dec 2011

Arab Health conference to discuss link between vitamin D deficiency and osteoporosis

Reports from the American University of Beirut Medical Centre have concluded that The Middle East and Africa region has the highest incidence of osteoporosis in the world, while UAE-based studies from the Emirates Osteoporosis Society (EOS) across Emiratis and expatriates show that one third of people in the UAE over the age of 50 suffer from osteoporosis. The society's findings also conclude that 78% of the UAE population, most notably Emirati women, suffer from Vitamin D deficiency, which is essential for good bone health, despite the abundance of sunshine.

19 Dec 2011

Scientists discover a way to keep normal and cancer cells alive in the lab

In a major step that could revolutionize biomedical research, scientists have discovered a way to keep normal cells as well as tumor cells taken from an individual cancer patient alive in the laboratory - which previously had not been possible. Normal cells usually die in the lab after dividing only a few times, and many common cancers will not grow, unaltered, outside of the body.

19 Dec 2011

Clinical trials highlight beneficial effect of CRT in heart failure

However, large-scale clinical trials have highlighted the beneficial effect of cardiac resynchronisation therapy (CRT) in the improvement of symptoms and reduction of mortality, and CRT is now recommended in the major European and American guidelines for the treatment and prevention of heart failure.

19 Dec 2011

ESC, SAGE to launch European Heart Journal: Acute Cardiovascular Care

SAGE and the European Society of Cardiology (ESC) have announced the launch of the European Heart Journal: Acute Cardiovascular Care.

19 Dec 2011

Increased Sirt1 expression protects against neurodegeneration in HD mouse model

Treatment that increases brain levels of an important regulatory enzyme may slow the loss of brain cells that characterizes Huntington's disease (HD) and other neurodegenerative disorders.

19 Dec 2011

Medical Condition News

UCL awarded 20M grant to establish The Leonard Wolfson Experimental Neurology Centre

Second-hand smoke exposure during childhood associated with aspirin-exacerbated respiratory disease

Studies confirm potential of EarlySense system as risk assessment tool for preventing pressure ulcers

Lixte's LB-205 shows therapeutic potential against Gaucher disease

ALS TDI, Biogen Idec and UCB enter agreement to study anti-CD40L antibody for ALS

Alkermes commences ALKS 9070 phase 3 clinical trial for schizophrenia

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

Zalicus commences Z944 Phase 1 clinical trial for treatment of acute and inflammatory pain

Soybean compounds can increase effectiveness of radiation treatment for lung cancer

IGN joins BCCA Genome Science Center

Diseases of the Colon & Rectum publishes results from Pacira's EXPAREL Phase 3 trial

arGEN-X to advance SIMPLE Antibody platform for treatment of autoimmune disorders

UCL to establish new center for treatment of neurodegenerative diseases

Study finds knee pain patterns vary among women over a 12-year period

The Academy of Nutrition and Dietetics to expand coverage of MNT

Arab Health conference to discuss link between vitamin D deficiency and osteoporosis

Scientists discover a way to keep normal and cancer cells alive in the lab

Clinical trials highlight beneficial effect of CRT in heart failure

ESC, SAGE to launch European Heart Journal: Acute Cardiovascular Care

Increased Sirt1 expression protects against neurodegeneration in HD mouse model

This International Women’s Day, Meet the Scientist Changing Women’s Healthcare

Microphysiological systems in drug discovery

Considerations for taking ASO discovery programs into animal models

Latest News